Table 1.

Primers used in this study

Viruses	Primer sequences (5′-3′)	Targeted genes	Position	Accession no.	Product size (bp)	Working concentration (μM)
FAdV	F: CAACAGCCTCTCGTACCCAG	Hexon	839–858	AJ459805	102	0.12
	R: CCGATGTAGTTGGGCCTGAG		921–940
DHAV	F: CTTTCCACTCCCTGCTCCC	VP1	510–528	KJ606043	140	0.12
	R: TTGGCTTCCACATCCTCTTCA		629–649
DEV	F: ATCGCATGTAGACGTTGGTT	UL2	726–745	EU885419	172	0.16
	R: AGACAGCGGTGATGGATGG		879–897
DTMUV	F: AATCGGTAGTGGCTTTGG	Envelope	432–449	AB110495	288	0.28
	R: AGTCTGCCGACATGGATAT		701–719
NDV	F: CACCGGCAACCCTATTCTGT	Fusion	853–872	M24701	330	0.28
	R: AGTGCGCCTTCAGTCTTTGA		1163–1182
AIV	F: GGCGACTACTACCAACCCA	Matrix	521–539	DQ064401	435	0.24
	R: CTGCTGTTCCTGCCGATAT		937–955
NDPV	F: TATGTCCTGGGCTCGGCTAC	VP3	448–467	EF014903	516	0.24
	R: AGCTGACACAGGTCCAGGTT		944–963